Galectin-3 may have potential as a biomarker for the early onset of cardiovascular disease in RA patients, potentially enabling early intervention and deferring the cardiovascular risks associated with RA…
MRI-Guided Therapy Offers No Improvement Over Conventional Treat to Target for RA
New research does not support the use of a magnetic resonance imaging (MRI)-guided strategy for treating RA patients. The study found that among RA patients in remission, an MRI-guided treat-to-target strategy compared with a conventional treat-to-target strategy did not result in improved disease activity remission rates or reduced radiographic progression…
Ohio Accuses UnitedHealth’s OptumRx of Drug Overcharges
(Reuters)—Ohio’s attorney general on Monday said he had filed a lawsuit against UnitedHealth Group Inc’s OptumRx unit, saying the pharmacy benefit manager had overcharged the state nearly $16 million for prescription drugs. Ohio Attorney General Dave Yost’s lawsuit followed a probe into the extent pharmacy benefit managers (PBMs) like OptumRx had engaged in pricing practices…
Knee Replacement in Younger Patients Has Higher Complication Rate
NEW YORK (Reuters Health)—Total knee replacement (TKA) is increasingly being performed in younger patients, and new research suggests that these patients have a higher risk for complications than older patients. “The number of knee replacements we are doing in younger and younger patients keeps increasing every year and we need to let these patients know…
Joining Forces to Advance Pediatric Rheumatology Care
Pediatric rheumatologists are in high demand. In fact, a shortage of pediatric rheumatologists requires more than half of all U.S. children with rheumatic diseases seek care with adult rheumatologists, and this shortage is projected to increase. For the past decade, the ACR’s Special Committee on Pediatric Rheumatology has worked to change this by bringing together…
Bringing a Frontline Perspective to Insurance Advocacy
Early in his career as a resident at Washington University in St. Louis, Mo., Christopher Phillips, MD, felt a connection to his patients battling rheumatic diseases. Today, Dr. Phillips balances time with his solo private practice in Paducah, Ky., to help rheumatologists fight insurance battles for their patients in his role as chair of the…
The RISE Registry: A Powerful Collaboration Tool for Clinicians & Researchers
Practice-based evidence, like that in the RISE registry, can be used to describe trends in patient care, look at comparative effectiveness of interventions and much more.
ACR Addresses Workforce Challenges at the State Level
Like many states in recent years, Georgia has struggled to provide patients with adequate access to rheumatologists and other cognitive specialists, with Georgia averaging 74,713 people per rheumatologist. Of equal concern, 31% of Georgia’s rheumatologists are approaching retirement age. During the current legislative session, the ACR has stepped up with a proposal to alleviate some…
FDA Approves Guselkumab Injector
The FDA has approved a single-press, self-injection device for a 100-mg dose of guselkumab for adults with moderate to severe plaque psoriasis…
Osteoporosis Experts Discuss Bisphosphonates, Chronic Kidney Disease
CHICAGO—The osteoporosis session at the 2018 ACR/ARHP Annual Meeting opened with a discussion by Kenneth Saag, MD, MSc, professor of medicine at the University of Alabama, Birmingham, in which he highlighted adverse events associated with osteoporosis medications. Dr. Saag began his presentation by emphasizing that, above all, the audience should keep in mind that the…
- « Previous Page
- 1
- …
- 274
- 275
- 276
- 277
- 278
- …
- 816
- Next Page »